Separation and isolation of trace impurities in L-tryptophan by high-performance liquid chromatography.
A high-performance liquid chromatographic (HPLC) profiling method was developed to separate trace impurities in L-tryptophan products associated with the eosinophilia-myalgia syndrome (EMS) epidemic. The test portion was dissolved in water, and the solution was filtered and chromatographed on a silica-based C18 reversed-phase HPLC column by using linear gradient elution with water and acetonitrile-water (80:20); both solvents contained 0.1% trifluoroacetic acid for ion-pairing. The method was used to profile 200 test samples from six manufacturers of L-tryptophan. The method was modified to include the use of a C18 disposable cartridge to retain the 1,1'-ethylidene-bis(L-tryptophan) (peak E, peak 97 or EBT), the impurity most strongly associated with EMS, and to remove the L-tryptophan before HPLC separation and quantitation. Recoveries of EBT added to test portions (2 micrograms/g and above) averaged 80%.
Trucksess
M W
MW
Division of Contaminants Chemistry, Food and Drug Administration, Washington, DC 20204.
D002851:Chromatography, High Pressure Liquid; D006801:Humans; D013056:Spectrophotometry, Ultraviolet; D014364:Tryptophan / Q000031:analogs & derivatives* / Q000032:analysis / Q000737:chemistry*
C070372:1,1'-ethylidene bis(tryptophan); D014364:Tryptophan